Loading company…
Zhejiang Starry Pharmaceutical Co., Ltd is a China-based developer of contrast agents and APIs, including iohexol.
Established in 1997, the company's iohexol products passed GMP certification and it obtained its GMP certificate in 2005. It listed on the Shanghai Stock Exchange in March 2013 under stock code 603520 and acquired Zhejiang Taizhou Haishen Pharmaceutical Co., Ltd in 2018. Its products include X-CT non-ionic contrast agents and fluoroquinolone series APIs such as levofloxacin.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in